Biography and Research Information
OverviewAI-generated summary
John Gaydos's research focuses on investigating novel therapeutic approaches for glioblastoma, a type of brain cancer. His work has explored the anti-glioblastoma activity of monensin and its analogs, utilizing an organoid model of cancer. This research aims to identify compounds that can effectively target and inhibit the growth of glioblastoma cells within a simulated tumor microenvironment. Gaydos has also contributed to a scoping review examining the effects of cold water immersion therapy on insulin levels. His scholarship metrics include an h-index of 1 with 2 total publications and 22 total citations. Gaydos collaborates with researchers at the University of Arkansas for Medical Sciences, including Robert L. Eoff, Alan J. Tackett, and Angus M. MacNicol, as well as Analiz Rodriguez at the University of Arkansas at Fayetteville.
Metrics
- h-index: 1
- Publications: 2
- Citations: 22
Selected Publications
-
Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer (2022)
-
Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer (2022)
Collaboration Network
Top Collaborators
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
- Monensin and its analogues show anti‐glioblastoma activity in an organoid model of cancer
- Cold water immersion therapy and effects on insulin: a scoping review
- Cold water immersion therapy and effects on insulin: a scoping review
Similar Researchers
Based on overlapping research topics